Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 17 Mar 2026 for Kyverna Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleMarc Grasso
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Marc Grasso: trading record in brief
Marc Grasso (finance chief) discloses dealings in 3 companies, chiefly Alector, Inc., Kura Oncology, Inc. and Kyverna Therapeutics, Inc. Over a trading history stretching from 26 January 2022 to 13 March 2026, the count stands at 15 filings.
Every open-market trade on record is a sale: 10 sales worth €229k. Besides market trades, the filings include 5 share grants.
The latest filing, published on 17 March 2026, reports a share grant in Kyverna Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Marc Grasso
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
10,000 shares0Common StockSEC:0001193125-26-110934:0
16,488 shares@ US$1.33848.4% of flowCommon StockSEC:0001415889-25-015591:0
18,091 shares@ US$1.467412.2% of flowCommon StockSEC:0000950170-25-033539:0
16,489 shares@ US$2.519418.8% of flowCommon StockSEC:0000950170-24-132913:0
216,400 shares0Common StockSEC:0000950170-24-111426:0
7,297 shares@ US$4.881515.4% of flowCommon StockSEC:0000950170-24-103454:0
6,920 shares@ US$4.798814.5% of flowCommon StockSEC:0000950170-24-068937:0
5,716 shares@ US$6.921217.4% of flowCommon StockSEC:0000950170-24-026427:0
4,574 shares@ US$5.5611.1% of flowCommon StockSEC:0000950170-23-068617:0
123,000 shares0Common StockSEC:0000950170-23-051705:0
1,114 shares@ US$5.19432.6% of flowCommon StockSEC:0000950170-23-046831:0
1,050 shares@ US$6.90373.2% of flowCommon StockSEC:0000950170-23-026477:0
1,291 shares@ US$8.31844.8% of flowCommon StockSEC:0001209191-23-016084:0
35,702 shares0Common StockSEC:0001209191-22-052568:0
21,900 shares0Common StockSEC:0001209191-22-005391:0
15 of 15 declarations
